Antioxidant activity of diethyldithiocarbamate

被引:54
作者
Liu, JK
Shigenaga, MK
Yan, LJ
Mori, A
Ames, BN
机构
[1] UNIV CALIF BERKELEY, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA
[2] OKAYAMA UNIV, SCH MED, INST MOLEC & CELLULAR BIOL, DEPT NEUROSCI, OKAYAMA 700, JAPAN
关键词
diethyldithiocarbamate (DDC); hypochlorous acid; hydroxyl radicals; DNA damage; NO toxicity;
D O I
10.3109/10715769609088045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diethyldithiocarbamate (DDC), a potent copper chelating agent, has long been used for the treatment of oxygen toxicity to the central nervous system, as an immunomodulator to treat cancer, and in HIV-infected patients. We evaluated the antioxidant properties of DDC, including its scavenging of reactive oxygen species, its reducing properties, its iron-chelating properties, and its protective effects on oxidant-induced damage to brain tissue, protein, human LDL, and DNA. It is found that DDC is a powerful reductant and antioxidant since it scavenges hypochlorous acid, hydroxyl radical and peroxynitrite; it chelates, then oxidizes ferrous ions; it blocks the generation of hydroxyl radicals and inhibits oxidative damage to deoxyribose, protein, DNA, and human LDL. These findings may provide an explanation for the apparent beneficial effects of DDC against oxidative stress-related diseases that have been observed in experimental and clinical studies.
引用
收藏
页码:461 / 472
页数:12
相关论文
共 46 条
[1]   THE IRON-BINDING AND HYDROXYL RADICAL SCAVENGING ACTION OF ANTI-INFLAMMATORY DRUGS [J].
ARUOMA, OI ;
HALLIWELL, B .
XENOBIOTICA, 1988, 18 (04) :459-470
[2]   ANTIOXIDANT EFFECT OF DIETHYLDITHIOCARBAMATE ON MICROSOMAL LIPID-PEROXIDATION ASSESSED BY LOW-LEVEL CHEMI-LUMINESCENCE AND ALKANE PRODUCTION [J].
BARTOLI, GM ;
MULLER, A ;
CADENAS, E ;
SIES, H .
FEBS LETTERS, 1983, 164 (02) :371-374
[3]  
BOND AM, 1984, COORDIN CHEM REV, V54, P23, DOI 10.1016/0010-8545(84)85017-1
[4]   REVERSAL OF DOPAMINE-REFRACTORY SEPTIC SHOCK BY DIETHYLDITHIOCARBAMATE, AN INHIBITOR OF ENDOTHELIUM-DERIVED RELAXING FACTOR [J].
BRONER, CW ;
SHENEP, JL ;
STOKES, DC ;
FAIRCLOUGH, D ;
HILDNER, WK ;
STORGION, SA ;
REHG, JE .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :141-147
[5]   LIGHT-DEPENDENT GENERATION OF SUPEROXIDE FROM HUMAN ERYTHROCYTES [J].
BYNOE, LA ;
GOTTSCH, JD ;
POU, S ;
ROSEN, GM .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1992, 56 (03) :353-356
[6]  
COUTELLIER A, 1992, PRESSE MED, V21, P1809
[7]  
DENEKE SM, 1979, J PHARMACOL EXP THER, V208, P377
[8]   SODIUM DITIOCARB AS ADJUVANT IMMUNOTHERAPY FOR HIGH-RISK BREAST-CANCER - A RANDOMIZED STUDY [J].
DUFOUR, P ;
LANG, JM ;
GIRON, C ;
DUCLOS, B ;
HAEHNEL, P ;
JAECK, D ;
JUNG, JM ;
OBERLING, F .
BIOTHERAPY, 1993, 6 (01) :9-12
[9]   THE IMPORTANCE OF SCHEDULE ON DIETHYLDITHIOCARBAMATE MODULATION OF DRUG-INDUCED MYELOSUPPRESSION [J].
EAST, CJ ;
BORCH, RF .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (02) :123-126
[10]   AN INVIVO STUDY OF THE RADIOPROTECTIVE EFFECT OF DIETHYLDITHIOCARBAMATE (DDC) [J].
EVANS, RG ;
ENGEL, CR ;
WHEATLEY, CL ;
NIELSEN, JR ;
CIBOROWSKI, LJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (11) :1635-1640